Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Clinical evaluation of zavegepant for the acute treatment of migraine.
Journal: Journal of managed care & specialty pharmacy
Published: May 30, 2025
Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system.
Journal: The journal of headache and pain
Published: May 23, 2025
Expert consensus on gepants for acute and preventive treatment of migraine in Thailand.
Journal: The journal of headache and pain
Published: April 23, 2025
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults.
Journal: Clinical pharmacology in drug development
Published: April 17, 2025
Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment.
Journal: Pain management
Published: April 16, 2025
The efficacy and safety of zavegepant nasal inhalation versus oral calcitonin-gene related peptide receptor antagonists in the acute treatment of migraine: a systematic review and network meta-analysis of the literature.
Journal: The journal of headache and pain
Published: January 21, 2025
A Pharmacokinetic Study of Zavegepant Nasal Spray in Healthy Adults Comparing Conventional Venous Blood Sampling With Patient-Centric Microsampling.
Journal: Clinical and translational science
Published: December 17, 2024
Health Technology Assessment: Evaluation of 8 CGRP-Targeted Therapy Drugs for the Treatment of Migraine.
Journal: Drug design, development and therapy
Published: November 03, 2024
Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial.
Journal: The journal of headache and pain
Published: September 27, 2024
The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative review.
Journal: Expert opinion on drug metabolism & toxicology
Published: September 25, 2024
Intranasal zavegepant for the acute treatment of migraine.
Journal: Expert review of neurotherapeutics
Published: September 24, 2024
Last Updated: 10/31/2025